Dr. Lal Path Labs Ltd. — Updates, 15-04-2025: Press Release

Dr. Lal PathLabs has launched an advanced test for Amyloidosis, making it the first diagnostic chain in South Asia to offer this specialized service. The test, known as Amyloid Typing by Laser Capture Microdissection & Mass Spectrometry, allows for accurate identification of various types of Amyloid proteins, which is critical for effective treatment planning.

This test is significant as Amyloidosis can lead to severe health issues with abnormal protein accumulation in vital organs. With over 40 types of Amyloid proteins identified, precise diagnosis is essential for tailored patient management. The test’s nationwide availability enables samples to be collected across India and sent to the National Reference Lab in New Delhi for analysis.

The launch reflects Dr. Lal PathLabs’ commitment to providing cutting-edge diagnostic solutions and enhancing patient care. CEO Shankha Banerjee emphasized the importance of bringing world-class diagnostics to India, while Dr. Alok Sharma highlighted the test as a gold standard in guiding treatment decisions. This innovation enhances Dr. Lal PathLabs' position in the healthcare market and may lead to improved patient outcomes.